Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/4/17 → 11/18/20 |
Funding
- Quintiles Incorporated: $29,021.00
A Phase 2b Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MED18897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
- Nachman, Sharon (PI)
- Beneri, Christy (CoPI)
- Maduekwe, Echezona (CoPI)
- Hymes, Saul (CoPI)
Project: Research